Microsoft Unveils AI Health Tool That Can Read Your Medical Records
via HealthDayFRIDAY, March 13, 2026 — Microsoft is rolling out a new artificial intelligence (AI) tool designed to help people manage their health.
The feature, called Copilot Health, works inside the company’s Copilot app and can provide personalized health advice using a user’s medical data, if the user chooses to share it.
With permission, the tool can review information such as test results, medical history, medications, doctor visit notes and data from wearable devices like Apple Watch or Fitbit.
Microsoft says the feature will launch first in the United States through a phased rollout.
“It’s something that Microsoft is uniquely placed to do with our scale, with our regulatory experience, with the kind of trust and confidence that people have in our security and the history that we have as a mature, stable player,” Mustafa Suleyman, chief executive of Microsoft’s AI division, told The Wall Street Journal.
Microsoft said health is already the most common topic folks ask about on the Copilot mobile app.
The new tool appears as a separate tab within the app. Users can connect hospital records, lab results and wearable health data to receive answers tailored to their situation.
If users choose not to connect their records, the chatbot can still provide more general health information.
Company leaders say the feature could be especially useful for people who are managing chronic health conditions.
The tool can connect to health data from more than 50,000 hospitals and provider organizations in the United States, according to Microsoft.
To use the service, users must confirm their identity through Clear, an identity verification system. Health records are then retrieved through HealthEx, a company that follows federal standards for sharing medical data.
Because medical records are highly sensitive, Microsoft says the data will be encrypted and kept separate from the normal Copilot chats.
Users can also manage or delete their information, the company said.
Microsoft says it worked with more than 230 physicians to help develop the system and review its safety.
Suleyman said the company is taking a “deliberate, slightly slower, more meticulous approach” to the initiative, given the sensitive nature of medical data.
The new feature is also part of Microsoft’s broader push to compete in the fast-growing AI market.
The company’s Copilot chatbot trails competitors such as OpenAI’s ChatGPT and Google’s Gemini in consumer use.
Microsoft hopes the health feature will attract more users to the app. The company plans to eventually charge for the service, but pricing has not been announced.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-03-14 01:36
Read more
- Chile Becomes First Country in the Americas To Eliminate Leprosy
- Drop in Daytime Activity Patterns Precedes Disability Worsening in MS
- FDA May Allow Some Flavored Vapes Aimed at Adults
- Umeclidinium-Vilanterol Tied to Better Outcomes Than Other LAMA-LABA Inhalers in Symptomatic COPD
- Novo Nordisk Expands U.S. Patient Access to FDA-Approved Semaglutide Medicines Through Hims & Hers in Response to a Shift in Their U.S. GLP-1 Business Model
- Most Americans Say They Don’t Trust Driverless Cars — Here’s Why
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions